10 results
Comparison of Pathologic Breathing Patterns
Biot's respiration aka ataxic respiration:
 - Periodic breathing: hyperpnea (or normopnea) and
Comparison of Pathologic ... : - Metabolic acidosis ... Sleep/Hypoxemia/Drugs ... #Respiratory #pulmonary ... #diagnosis #comparison
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Microbiologically Confirmed Pulmonary ... #Tuberculosis #ActiveTB ... Therapy #regimens #medications ... IDSA #Guidelines #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... Tuberculosis Diagnosis ... Tuberculosis Treatment ... Tuberculosis #TB #Diagnosis ... #Management #Treatment
Causes of Lactate Elevation, Lactic Acidosis - Differential Diagnosis

The most common causes of hyperlactatemia are usually:
circulation If drugs ... before beginning treatment ... output - Acute pulmonary ... Alcohol • Type B2: Drugs ... - HIV/HAART medications
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... Tuberculosis Diagnosis ... Tuberculosis Treatment ... Tuberculosis #TB #Diagnosis ... #Management #Treatment
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
Lymphadenitis, pulmonary ... lymphadenitis, pulmonary ... , hypoxia, and pulmonary ... • Persistently active ... infection/drug
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
prevent TB disease) Indications ... no evidence of active ... for active or latent ... authorities Treating Active ... and molecular diagnostic
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Disease: • 10%-15% Pulmonary ... , INC risk PE, Pulmonary ... renal tubular acidosis ... Adenocarcinoma Treatment ... muscarinic agonists • Active
Causes of Unintentional Weight Loss - Differential Diagnosis
Malignancy 
 - Tumor effect* (esp. Gl, lung, lymphoma)
- Differential Diagnosis ... lymphoma) - Treatment ... cachexia"), COPD ("pulmonary ... cachexia") Medications ... GLP-I agonists Drugs
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
syndromes current treatment ... median age at diagnosis ... influence outcomes and treatment ... cardiovascular or pulmonary ... Three drugs have